- #1225685
- 19
- Binx Health #1.002.101
Molecular Reagent binx io® Chlamydia Trachomatis / Neisseria Gohorrhoeae (CT / NG) For io Instrument 50 Tests
ASSAY, CT/NG BINX HEALTH IO SNGL-USE CARTRIDGE (50/CS) D/S
Features
- Single use cartridge (10 Tests per pack, 5 Packs per Case)
- The binx health io CT/NG Assay, when tested using the binx health io Instrument, is a fully automated, rapid, qualitative test intended for use in point-of-care or clinical laboratory settings for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA by polymerase chain reaction
- The binx health io CT/NG test, designed to be performed in the clinic or decentralized laboratory while the patient waits, can enable immediate treatment of positive patients, removing the need for presumptive treatment, improving compliance, and reducing loss to follow-up
- More …
Product Details Email
Product Specifications
McKesson # | 1225685 |
Manufacturer # | 1.002.101 |
Brand | binx io® |
Manufacturer | Binx Health |
Country of Origin | China |
Application | Molecular Reagent |
CLIA Classification | CLIA Waived |
CLIA Classified | CLIA Waived |
For Use With | For io Instrument |
Number of Tests | 50 Tests |
Sample Type | Urine / Vaginal Swab Sample |
Specialty | Molecular |
Test Category | Sexual Health |
Test Format | Cartridge |
Test Name | Chlamydia Trachomatis / Neisseria Gohorrhoeae (CT / NG) |
Test Type | Molecular Diagnostic |
Time to Results | 30 Minute Results |
UNSPSC Code | 41116011 |
Features
- Single use cartridge (10 Tests per pack, 5 Packs per Case)
- The binx health io CT/NG Assay, when tested using the binx health io Instrument, is a fully automated, rapid, qualitative test intended for use in point-of-care or clinical laboratory settings for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA by polymerase chain reaction
- The binx health io CT/NG test, designed to be performed in the clinic or decentralized laboratory while the patient waits, can enable immediate treatment of positive patients, removing the need for presumptive treatment, improving compliance, and reducing loss to follow-up
- First ever FDA 510(k), CLIA-Waived CT/NG molecular test for males and females, enabling same-visit diagnosis and treatment
- Gives results comparable to a laboratory-based test for chlamydia and gonorrhea in about 30 minutes rather than days or weeks
- The binx health io CT/NG Assay is intended for use with female vaginal swab specimens, collected either by a clinician or self-collected by a patient in a clinical setting, or male urine specimens, as an aid in the diagnosis of symptomatic or asymptomatic Chlamydia trachomatis and/or Neisseria gonorrhoeae infection
Professionals Also Viewed
- #1080512
- 398
- Cepheid #XPRSTREPA-10
- Xpert® Xpress Strep A is a qualitative real-time PCR test providing ac …
- Xpert® Xpress Strep A provides medically actionable and timely informa …
- For In Vitro Diagnostic Use
- #1045073
- 216
- Cepheid #GXCT/NG-10
- 90 minute detection and differentiation of Chlamydia trachomatis (CT) …
- #931480
- BD #441124
- Qualitative detection of Neisseria gonorrhoeae DNA in clinician-collec …
- #1177911
- 117
- Roche #09211101190
- The cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test is for use on t …
- Product ships from McKesson with minimum 30 days dating
- Emergency use of this test is limited to authorized laboratories: Labo …